ALTA is a service-provider company specialized in developing and managing scientific research projects.

The mission of ALTA is to support research activities from the idea to the realization of project.

ALTA assists in finding the proper strategy, building European Consortia and putting science in the most appropriate administrative and management framework.

download PDF file PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020


HEALTH:

dot HEP-CAR
  Mechanisms underlying hepatocellular carcinoma pathogenesis
  and impact of comorbidities
(Universitaetsklinikum Freiburg)


MARIE SKLODOWSKA-CURIE ACTIONS
Innovative Training Networks (ITN) – European Training Networks (ETN):

dot GLYCOVAX
  A training network for the rational design of the next generation of
  well-defined glycoconjugate vaccines
(Novartis)

 

dot PANDORA
  Probing safety of nano-objects by defining immune responses of
  environmental organisms
  
(Consiglio Nazionale delle Ricerche – Istituto di Biochimica delle Proteine)

download PDF file PROJECTS APPROVED IN THE 2014 CALL - HORIZON 2020


HEALTH:

dot ImmunoAgeing
  An integrated approach to dissect determinants, risk factors and
  pathways of ageing of the immune system disease
  
(Consiglio Nazionale delle Ricerche - Istituto di Ricerca Genetica e Biomedica)


MARIE SKLODOWSKA-CURIE ACTIONS - Individual Fellowships (IF):

dot SVnanoVAX
  Structural Vaccinology in the design of bionanoparticles with multi-copy
  antigen display for vaccines with enhanced efficacy
(Novartis)

 

dot NEWCARBOVAX
  New generation of carbohydrate-based vaccines via rational
  understanding of their immunological mechanism
(Novartis)

download PDF file ISO 9001


Our company is in the process of planning, development and implementation of a quality management system in accordance with the standard UNI EN ISO 9001:2008

PROJECTS APPROVED IN THE LAST CALL - FP7/Health


dot Athero-B-Cell
  Targeting and exploiting B cell functions for treatment in cardiovascular
  disease
(University of Oxford)

 

dot Athero-Flux
  Targeting novel lipid pathways for treatment of cardiovascular disease   (University of Oxford)

 

dot HERACLES
  Human cystic Echinococcosis ReseArch in CentraL and Eastern Societies   (Istituto Superiore di Sanità)

 

dot BioCog
  Biomarker Development for Postoperative Cognitive Impairment in the
  Elderly
(Charité- Universitätsmedizin Berlin)





ALTA channels
ALTA on Facebook ALTA on Linkedin ALTA YouTube channel

Last update: February 02, 2016


September, 2015
PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020

HEALTH:

dot HEP-CAR
Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of comorbidities
(Universitaetsklinikum Freiburg)

June, 2015
PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020

MARIE SKLODOWSKA-CURIE ACTIONS Innovative Training Networks (ITN) – European Training Networks (ETN):

dot GLYCOVAX
A training network for the rational design of the next generation of well-defined glycoconjugate vaccines (Novartis)

dot PANDORA
Probing safety of nano-objects by defining immune responses of environmental organisms (Consiglio Nazionale delle Ricerche – Istituto di Biochimica delle Proteine)


April, 2015
The second call for the iCARE fellowships has been published.
iCare Fellowships 2015 pdf


january, 2015
PROJECTS APPROVED IN THE 2014 CALL - HORIZON 2020

HEALTH:

dot ImmunoAgeing
An integrated approach to dissect determinants, risk factors and pathways of ageing of the immune system disease
(Consiglio Nazionale delle Ricerche - Istituto di Ricerca Genetica e Biomedica)

MARIE SKLODOWSKA-CURIE ACTIONS - IF:

dot SVnanoVAX
Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy (Novartis)

dot NEWCARBOVAX
New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism (Novartis)


news archive News archive

   © 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy
   tel +39 0577 50518 fax +39 0577 593815
   e.mail: info@altaweb.eu
   capitale sociale € 10.845,00
   R.e.a 112828
   C.F. 12364330154 P.IVA 01033520527